Reports Q4 revenue $86.3M, consensus $83.89M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSTL:
- Lake Street raises Castle Biosciences 2025 estimates after Novitas delay
- Castle Biosciences to share data on DecisionDx-SCC
- Castle Biosciences Projects Strong Revenue Growth for 2024
- Castle expects FY24 revenue to meet or exceed top end of $320M-$330M guidance
- Castle Biosciences drops as regional Medicare contractor won’t cover test